Patents by Inventor Su Jin Kang
Su Jin Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240099132Abstract: The present invention relates to an organic electroluminescent device comprising at least one light-emitting layer between an anode and a cathode, wherein the light-emitting layer comprises a host and a phosphorescent dopant; the host comprises plural host compounds; at least a first host compound of the plural host compounds has a structure of a nitrogen-containing heterocyclic linker bonded to a nitrogen atom of a carbazole of an indole-carbazole, indene-carbazole, benzofuran-carbazole, or benzothiophene-carbazole residue; and a second host compound has a carbazole-aryl-carbazole or carbazole-carbazole structure. According to the present invention, by using a specific multi-component host different from the conventional organic electroluminescent device, an organic electroluminescent device of significantly improved lifespan is provided.Type: ApplicationFiled: November 15, 2023Publication date: March 21, 2024Inventors: Kyoung-Jin PARK, Bitnari KIM, Yoo-Jin DOH, Hyun-Ju KANG, Young-Mook LIM, Su-Hyun LEE, Chi-Sik KIM
-
Publication number: 20240083811Abstract: A glass article includes a first surface, a second surface opposed to the first surface, a first compressive region extending from the first surface to a first compression depth, a second compressive region extending from the second surface to a second compression depth and a tensile region between the first compression depth and the second compression depth. A stress profile of the first compressive region includes a first segment located between the first surface and a first transition point and a second segment located between the first transition point and the first compression depth. A depth from the first surface to the first transition point ranges from 6.1 ?m to 8.1 ?m. A compressive stress at the first transition point ranges from 207 MPa to 254 MPa. A stress-depth ratio of the first transition point ranges from 28 MPa/?m to 35 MPa/?m.Type: ApplicationFiled: November 20, 2023Publication date: March 14, 2024Inventors: Gyu In SHIM, Seung KIM, Byung Hoon KANG, Young Ok PARK, Su Jin SUNG
-
Publication number: 20240079258Abstract: Disclosed in the present document is an apparatus for aligning a semiconductor chip for packaging according to an embodiment, the apparatus may include a radiation source configured to irradiate a plurality of semiconductor chips with radiation; the plurality of semiconductor chips vertically disposed with respect to the ground; a radiation sensor configured to detect the radiation that has penetrated the plurality of semiconductor chips; and an alignment unit configured to align and bond the plurality of semiconductor chips based on detection information acquired by the radiation sensor.Type: ApplicationFiled: September 1, 2023Publication date: March 7, 2024Inventors: Chang Goo KANG, Jeong Min PARK, Su Jin KIM
-
Patent number: 11912613Abstract: A glass article includes lithium aluminosilicate, includes a first surface, a second surface opposed to the first surface, a first compressive region extending from the first surface to a first compression depth, a second compressive region extending from the second surface to a second compression depth, and, a tensile region disposed between the first compression depth and the second compression depth, where a stress profile of the first compressive region has a first local minimum point at which the stress profile is convex downward and a first local maximum point at which the stress profile is convex upward, where a depth of the first local maximum point is greater than a depth of the first local minimum point, and where a stress of the first local maximum point is greater than a compressive stress of the first local minimum point.Type: GrantFiled: July 10, 2020Date of Patent: February 27, 2024Assignee: SAMSUNG DISPLAY CO., LTD.Inventors: Su Jin Sung, Byung Hoon Kang, Seung Kim, Young Ok Park, Gyu In Shim
-
Patent number: 11912603Abstract: A glass article includes a first surface; a second surface opposed to the first surface; a side surface connecting the first surface to the second surface; a first surface compressive region extending from the first surface to a first depth; a second surface compressive region extending from the second surface to a second depth; and a side compressive region extending from the side surface to a third depth, where the first surface and the side surface are non-tin surfaces, the second surface is a tin surface, and a maximum compressive stress of the second surface compressive region is greater than a maximum compressive stress of the first surface compressive region.Type: GrantFiled: January 8, 2021Date of Patent: February 27, 2024Assignee: SAMSUNG DISPLAY CO., LTD.Inventors: Su Jin Sung, Byung Hoon Kang, Seung Kim, Young Ok Park, Gyu In Shim
-
Publication number: 20230242584Abstract: The present invention relates to novel polypeptides having a skin whitening activity and use thereof. More particularly, the present invention relates to an isolated polypeptide consisting (essentially) of any one amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, and SEQ ID NO: 7, a skin whitening cosmetic composition comprising the polypeptide as an active ingredient, or a pharmaceutical composition for preventing or treating a pigmentation disease.Type: ApplicationFiled: January 23, 2020Publication date: August 3, 2023Applicant: Metapore Co.., LtdInventors: Min Chul PARK, Ji Na KIM, Su Jin KANG
-
Publication number: 20220268787Abstract: The present invention relates to an antibody specifically binding to a tryptophanyl-tRNA synthetase (WRS) protein and, more specifically, to: an antibody, or a fragment of the antibody, specifically binding to a polypeptide of an amino acid sequence represented by SEQ ID NO: 2 in a WRS protein; a polynucleotide encoding the antibody and a vector comprising same; a cell transformed using same; and a use thereof.Type: ApplicationFiled: July 17, 2020Publication date: August 25, 2022Inventors: Sumi BAE, Sunghwa SON, Yunsun KIM, Jieun PARK, Min Chul PARK, Su Jin KANG
-
Publication number: 20220252601Abstract: The present invention relates to an antibody specifically binding to a WRS (tryptophanyl-tRNA synthetase) protein, and a use thereof. More specifically, the present invention pertains to an antibody specifically binding to a polypeptide of an amino acid sequence represented by SEQ ID NO:2 in the WRS (tryptophanyl-tRNA synthetase) protein, or a fragment of the antibody, a polynucleotide encoding the antibody, a vector comprising the polynucleotide, a cell transformed using the vector, and a use of the cell.Type: ApplicationFiled: July 17, 2020Publication date: August 11, 2022Inventors: Sumi BAE, Sunghwa SON, Yunsun KIM, Jieun PARK, Min Chul PARK, Su Jin KANG
-
Patent number: 9693084Abstract: In one example embodiment, a method performed under control of a wearable video playing device includes: transmitting identifying information for a location of the wearable video playing device to a video content provider; receiving, from the video content provider, video content information regarding a plurality of video contents recorded near the location; displaying, on a user interface, at least one video content identifier respectively corresponding to the video contents, wherein the at least one video content identifier is associated with the location; receiving an input to select one of the at least one video content identifier; and playing video content, from among the plurality of video contents recorded near the location, corresponding to the selected video content identifier.Type: GrantFiled: December 30, 2014Date of Patent: June 27, 2017Assignee: KT CorporationInventors: Yong-jun Song, Su-jin Kang, Woo-hyun Kwon
-
Patent number: 9560087Abstract: The disclosure is related to providing a machine to machine (M2M0 service. A user interface (UI) template associated with a M2M device may be retrieved when a message is received from the M2M device. Then, data collected from the M2M device may be combined with the retrieved UI template. The M2M service associated with the M2M device may be provided by embedding the combined data to application data for producing a M2M service user interface (UI) of the associated M2M service.Type: GrantFiled: February 22, 2013Date of Patent: January 31, 2017Assignee: KT CORPORATIONInventors: Su-Jin Kang, Sung-Phil Heo, Sang-Eon Kim, Yeon-Soo Kim, Han-Wook Jung
-
Publication number: 20160081979Abstract: The present invention provides a method for separating and preparing a therapeutic agent for chronic myelogenous leukimeia capable of effectively inhibiting growth of T315I, which is known as a mutation of a BCR-ABL fusion gene that causes chronic myelogenous leukemia, comprising the steps of: 1) preliminary extracting by adding ethyl acetate to finely chopped bark of Liriodendron tulipifera L., adding butanol to an extracted fluid for layer-separating an ethyl acetate layer and a butanol layer, removing the butanol layer, and decompression-condensing the remainder to obtain a crude extract; and 2) adding a C1-C3 lower alcohol aqueous solution and n-hexane to the obtained crude extract, removing lipids and water insoluble material dissolved in the n-hexane layer, and obtaining and separating a lower alcohol aqueous solution layer to separate and refine highly pure epi-tulipinolide and costunolide.Type: ApplicationFiled: April 23, 2014Publication date: March 24, 2016Applicant: CHO DANG PHARM. CO., LTD.Inventors: Ki Woon KIM, Hye Dong YOO, Yong Hwan KIM, Il Kyong HWANG, Young Seon KIM, Mi Jung JU, Su Jin KANG
-
Publication number: 20160081978Abstract: The present invention relates to a pharmaceutical composition containing, as an active ingredient, a Liriodendron tulipifera L. bark extract for treating chronic myelogneous leukemia. More specifically, the present invention relates to the pharmaceutical composition, containing, as the active ingredient, the Liriodendron tulipifera L. bark extract useful in selectively inhibiting mutant enzyme T315I from a mutation of a BCR-ABL fusion gene that causes chronic myelogenous leukemia, and to a use of epi-Tulipinolide which is an active ingredient of the composition.Type: ApplicationFiled: April 23, 2014Publication date: March 24, 2016Applicant: CHO DANG PHARM. CO., LTD.Inventors: Ki Woon KIM, Hye Dong YOO, Soon Sun HONG, Soo Jung KIM, Hyun Seung LEE, Zhenghuan FANG, Su Jin KANG
-
Publication number: 20150189345Abstract: In one example embodiment, a method performed under control of a wearable video playing device includes: transmitting identifying information for a location of the wearable video playing device to a video content provider; receiving, from the video content provider, video content information regarding a plurality of video contents recorded near the location; displaying, on a user interface, at least one video content identifier respectively corresponding to the video contents, wherein the at least one video content identifier is associated with the location; receiving an input to select one of the at least one video content identifier; and playing video content, from among the plurality of video contents recorded near the location, corresponding to the selected video content identifier.Type: ApplicationFiled: December 30, 2014Publication date: July 2, 2015Inventors: Yong-jun SONG, Su-jin KANG, Woo-hyun KWON
-
Patent number: 8936900Abstract: A molecular glass compound comprises a vinyl ether adduct of an aromatic vinyl ether of formula C(R1)2?C(R2)—O-(L)n-Ar1, and a calix[4]arene, wherein R1 and R2 are each independently a single bond, H, C1-20 alkyl, C1-20 haloalkyl, C6-20 aryl, C6-20 haloaryl, C7-20 aralkyl, or C7-20 haloaralkyl, L is a C1-20 linking group, n is 0 or 1, and Ar1 is a halo-containing monocyclic, or substituted or unsubstituted polycyclic or fused polycyclic C6-20 aromatic-containing moiety, wherein R1 and R2 are connected to Ar1 when either or both of R1 and R2 is a single bond and n is 0. A photoresist, comprising the molecular glass compound, a solvent, and a photoacid generator, a coated substrate, comprising (a) a substrate having one or more layers to be patterned on a surface thereof; and (b) a layer of a photoresist composition over the one or more layers to be patterned, and a method of forming the molecular glass compound, are also disclosed.Type: GrantFiled: September 21, 2012Date of Patent: January 20, 2015Assignees: Rohm and Haas Electronic Materials LLC, Dow Global Technologies LLCInventors: Vipul Jain, D. Patrick Green, James W. Thackeray, Brad C. Bailey, Su Jin Kang
-
Patent number: 8703383Abstract: A copolymer has formula: wherein R1-R5 are independently H, C1-6 alkyl, or C4-6 aryl, R6 is a fluorinated or non-fluorinated C5-30 acid decomposable group; each Ar is a monocyclic, polycyclic, or fused polycyclic C6-20 aryl group; each R7 and R8 is —OR11 or —C(CF3)2OR11 where each R11 is H, a fluorinated or non-fluorinated C5-30 acid decomposable group, or a combination; each R9 is independently F, a C1-10 alkyl, C1-10 fluoroalkyl, C1-10 alkoxy, or a C1-10 fluoroalkoxy group; R10 is a cation-bound C10-40 photoacid generator-containing group, mole fractions a, b, and d are 0 to 0.80, c is 0.01 to 0.80, e is 0 to 0.50 provided where a, b, and d are 0, e is greater than 0, the sum a+b+c+d+e is 1, l and m are integers of 1 to 4, and n is an integer of 0 to 5. A photoresist and coated substrate, each include the copolymer.Type: GrantFiled: November 17, 2011Date of Patent: April 22, 2014Assignee: Rohm and Haas Electronic Materials LLCInventors: James W. Thackeray, Emad Aqad, Su Jin Kang, Owendi Ongayi
-
Publication number: 20120129105Abstract: A copolymer has formula: wherein R1-R5 are independently H, C1-6 alkyl, or C4-6 aryl, R6 is a fluorinated or non-fluorinated C5-30 acid decomposable group; each Ar is a monocyclic, polycyclic, or fused polycyclic C6-20 aryl group; each R7 and R8 is —OR11 or —C(CF3)2OR11 where each R11 is H, a fluorinated or non-fluorinated C5-30 acid decomposable group, or a combination; each R9 is independently F, a C1-10 alkyl, C1-10 fluoroalkyl, C1-10 alkoxy, or a C1-10 fluoroalkoxy group; R10 is a cation-bound C10-40 photoacid generator-containing group, mole fractions a, b, and d are 0 to 0.80, c is 0.01 to 0.80, e is 0 to 0.50 provided where a, b, and d are 0, e is greater than 0, the sum a+b+c+d+e is 1, l and m are integers of 1 to 4, and n is an integer of 0 to 5. A photoresist and coated substrate, each include the copolymer.Type: ApplicationFiled: November 17, 2011Publication date: May 24, 2012Applicant: ROHM AND HAAS ELECTRONIC MATERIALS LLCInventors: James W. Thackeray, Emad Aqad, Su Jin Kang, Owendi Ongayi
-
Patent number: 8076284Abstract: Antimicrobial and anticancer peptides engineered using Gaegurin 5 isolated from Korean frog (Rana rugosa), which have a smaller structure compared with previously known Gaegurin peptides and show potent antimicrobial and anticancer activity. Specifically, the antimicrobial and anticancer peptides synthesized from the shortest length of Gaegurin 5, show potent antimicrobial activity against gram positive and negative strains, good safety with very low hemolytic activity and favorable advantages such as drug absorption and drug transportation due to its advantageous structural property, which can be useful as a potent antimicrobial or anticancer agent.Type: GrantFiled: May 14, 2007Date of Patent: December 13, 2011Assignee: Promeditech, Inc.Inventors: Bong Jin Lee, Min Duk Seo, Su Jin Kang, Hyun Jung Kim
-
Publication number: 20100105626Abstract: The present invention is related to antimicrobial and anticancer peptide engineering using Gaegurin 5 isolated from Korean frog (Rana rugosa), which have smaller structure compared with previously known Gaegurin peptide and shows potent antimicrobial and anticancer activity. Specifically, the antimicrobial and anticancer peptide of the present invention synthesized from the shortest length of Gaegurin 5, show potent antimicrobial activity against gram positive and negative strains, good safety with very low hemolytic activity and favorable advantages such as drug absorption and drug transportation due to its advantageous structural property, which can be useful as a potent antimicrobial or anticancer agent.Type: ApplicationFiled: May 14, 2007Publication date: April 29, 2010Applicant: PROMEDITECH, INCInventors: Bong Jin LEE, Min Duk SEO, Su Jin KANG, Hyun Jung KIM